B
iocon, Asiais premier biotechnology company, and Quark Pharmaceuticals, Inc, a world leader in the discovery and development of siRNA -based therapeutics, have entered into a Licensing & Collaboration agreement for the development of a range of siRNA (small interfering RNA) based novel therapeutics.
https://www.epicresearch.co/
No comments:
Post a Comment